Skip to content Menu
Science Chronicle

Science Chronicle

A Science and Technology Blog

Sidebar
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad

Category: Molnupiravir

Posted on January 9, 2022January 10, 2022

Conflicting signals from drug regulator, COVID-19 national task force

“Considering the emergency and unmet medical need in Covid-19, the SEC on December 27 recommended for grant of permission to manufacture and market the Molnupiravir for restricted use under emergency…

Continue Reading
Posted on December 25, 2021

Two COVID-19 antivirals get FDA nod for emergency use

Unlike in the case of remdesivir, both the drugs — Pfizer’s paxlovid and Merck’s molnupiravir — are oral pills and so can be administered outside hospital settings. These drugs are…

Continue Reading
Posted on November 20, 2021November 20, 2021

Pfizer’s antiviral Paxlovid is a major advancement potentially for all coronaviruses, says Gagandeep Kang

In an email, Dr. Gagandeep Kang, Professor of Microbiology at CMC Vellore explains the significance of paxlovid antiviral for treatment, its mode of action, and the need for a combination…

Continue Reading
Posted on October 28, 2021

SARS-CoV-2 virus less likely to develop resistance to molnupiravir: Gagandeep Kang

Preliminary data, which is yet to be peer-reviewed, shows molnupiravir can reduce risk of hospitalisation or death by 50% in non-hospitalised adult patients with mild-to-moderate COVID-19 disease. The trial included…

Continue Reading
Follow Science Chronicle on WordPress.com

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 10,850 other followers

Archives

Social

  • View Prasad.Ravindranath’s profile on Facebook
  • View @RPrasad12’s profile on Twitter
  • View Prasad.Ravindranath@gmail.com’s profile on Google+

Recent Posts

  • Booster doses only mitigate disease severity, do not fully prevent infection January 11, 2022
  • Are there clinical trial data to support a homologous vaccine booster? January 9, 2022
  • Conflicting signals from drug regulator, COVID-19 national task force January 9, 2022
  • Even if mild, Omicron variant can overwhelming health-care settings January 9, 2022
  • Does Covaxin have WHO’s approval for use in children? January 5, 2022

Most Read Posts

  • 65 papers from India retracted for image falsification/fabrication, errors
  • Loosening the vice-like grip of chewing tobacco
  • UGC’s revised white list has 71 active predatory journals
  • 127 papers from India retracted for image duplication, manipulation
  • Department of Applied Chemistry, IIT Dhanbad has 45 papers with duplicated, manipulated images
  • Authorship in 73 journal papers from India up for sale
  • Explained: How litchi toxin is causing deaths in undernourished children in Muzaffarpur
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
  • Home
  • PODCASTS
  • About
  • ARCHIVES
  • Award for R. Prasad
Create a website or blog at WordPress.com
Top
Follow Science Chronicle on WordPress.com

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 10,850 other followers

Archives

  • Follow Following
    • Science Chronicle
    • Join 10,850 other followers
    • Already have a WordPress.com account? Log in now.
    • Science Chronicle
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar